BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3923026)

  • 1. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
    Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
    J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC; Chen FW; Hsieh HC
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
    Barbarino A; De Marinis L; Maira G; Menini E; Anile C
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.
    Arafah BM; Nekl KE; Gold RS; Selman WR
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
    Hoyte KM; Martin JB
    J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
    Schlechte JA; Sherman BM; Chapler FK; VanGilder J
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
    Arafah BM
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of thyroid stimulating hormone levels in acromegalic patients after selective adenomectomy.
    Tsuchiya H; Onishi T; Mori S; Lee S; Kohno H; Imanaka S; Saitoh Y; Mogami H; Uozumi T; Kumahara Y
    Endocrinol Jpn; 1984 Dec; 31(6):687-95. PubMed ID: 6442697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.
    Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G
    J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of diabetes mellitus on thyrotropin response to thyrotropin-releasing hormone in untreated acromegalic patients.
    Shigemasa C; Abe K; Taniguchi S; Mitani Y; Ueta Y; Adachi T; Urabe K; Tanaka T; Yoshida A; Hori T
    J Endocrinol Invest; 1988 Apr; 11(4):231-7. PubMed ID: 3137252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
    Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive features of prolactin secretion in acromegalic patients with hyperprolactinaemia.
    Serri O; Robert F; Comtois R; Jilwan N; Beauregard H; Hardy J; Somma M
    Clin Endocrinol (Oxf); 1987 Oct; 27(4):429-36. PubMed ID: 3124991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenomas in acromegalic patients: an immunohistochemical and endocrinological study with special reference to prolactin-secreting adenoma.
    Kanie N; Kageyama N; Kuwayama A; Nakane T; Watanabe M; Kawaoi A
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1093-101. PubMed ID: 6415083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The results of transsphenoidal surgery for 44 consecutive acromegalic patients.
    Yamada S; Takada K; Ozawa Y; Shimizu T; Sawano S; Shishiba Y; Sano T; Usui M
    Endocr J; 1997 Jun; 44(3):395-402. PubMed ID: 9279515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone and prolactin secretion in acromegaly: correlations between hormonal dynamics and immunocytochemical findings.
    Bassetti M; Arosio M; Spada A; Brina M; Bazzoni N; Faglia G; Giannattasio G
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1195-204. PubMed ID: 3142915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective regulation of prolactin secretion after successful removal of prolactinomas.
    Camanni F; Ghigo E; Ciccarelli E; Massara F; Campagnoli C; Molinatti G; Müller EE
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1270-6. PubMed ID: 6415087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.